0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Integrated Polymer Fibers Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-36P3601
Home | Market Reports | Business & Industrial | Chemicals Industry | Plastics & Polymers
Global Drug Integrated Polymer Fibers Market Insights and Forecast to 2028

Global Drug Integrated Polymer Fibers Market Insights and Forecast to 2028

Code: QYRE-Auto-36P3601
Report
January 2022
71 Pages
QYResearch
Region: Global, Saudi Arabia, Turkey, North America, Europe, Canada, Germany, France, Japan, Argentina, India, Australia, Taiwan, Middle East & Africa, Brazil, Vietnam, Indonesia, Thailand, Malaysia, Philippines, Italy, South Korea,
Description
Table of Content
Tables & Figures
Drug integrated polymer fibers are used to create implantable textile devices using a combination of resorbable as well as non-resorbable polymers. These devices can be made from different materials and are available in custom sizes and shapes to meet specific biological requirements. With a rise in complexity along with technological innovations, textile devices are being designed to meet a broader range of applications than earlier which will boost the demand of drug integrated polymer fibers. Textiles are being considered as the logical choice for soft tissue repair including hernias, ligaments and tendons due to its fibrous nature of human body.
Market Analysis and Insights: Global Drug Integrated Polymer Fibers Market

Due to the COVID-19 pandemic, the global Drug Integrated Polymer Fibers market size is estimated to be worth US$ 61 million in 2022 and is forecast to a readjusted size of US$ 76 million by 2028 with a CAGR of 3.8% during the review period.

Fully considering the economic change by this health crisis, Polylactic Acid accounting for % of the Drug Integrated Polymer Fibers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Drug Delivery segment is altered to an % CAGR throughout this forecast period.
China Drug Integrated Polymer Fibers market size is valued at US$ million in 2021, while the US and Europe Drug Integrated Polymer Fibers are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Drug Integrated Polymer Fibers landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Drug Integrated Polymer Fibers include TissueGen, Micro Engineering Solutions and Integrated Polymer Solutions, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Drug Integrated Polymer Fibers Scope and Segment
Drug Integrated Polymer Fibers market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Drug Integrated Polymer Fibers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Polylactic Acid
Polydioxanone
Polycaprolactone

Segment by Application

Drug Delivery
Orthopaedic Sutures
Vascular Stents
Vascular Grafts
Dermal Wound Healing

BY COMPANY

TissueGen
Micro Engineering Solutions
Integrated Polymer Solutions

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Drug Integrated Polymer Fibers Product Introduction
1.2 Market by Type
1.2.1 Global Drug Integrated Polymer Fibers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Polylactic Acid
1.2.3 Polydioxanone
1.2.4 Polycaprolactone
1.3 Market by Application
1.3.1 Global Drug Integrated Polymer Fibers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Drug Delivery
1.3.3 Orthopaedic Sutures
1.3.4 Vascular Stents
1.3.5 Vascular Grafts
1.3.6 Dermal Wound Healing
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drug Integrated Polymer Fibers Sales Estimates and Forecasts 2017-2028
2.2 Global Drug Integrated Polymer Fibers Revenue Estimates and Forecasts 2017-2028
2.3 Global Drug Integrated Polymer Fibers Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drug Integrated Polymer Fibers Sales by Region
2.4.1 Global Drug Integrated Polymer Fibers Sales by Region (2017-2022)
2.4.2 Global Sales Drug Integrated Polymer Fibers by Region (2023-2028)
2.5 Global Drug Integrated Polymer Fibers Revenue by Region
2.5.1 Global Drug Integrated Polymer Fibers Revenue by Region (2017-2022)
2.5.2 Global Drug Integrated Polymer Fibers Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drug Integrated Polymer Fibers Sales by Manufacturers
3.1.1 Global Top Drug Integrated Polymer Fibers Manufacturers by Sales (2017-2022)
3.1.2 Global Drug Integrated Polymer Fibers Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug Integrated Polymer Fibers in 2021
3.2 Global Drug Integrated Polymer Fibers Revenue by Manufacturers
3.2.1 Global Drug Integrated Polymer Fibers Revenue by Manufacturers (2017-2022)
3.2.2 Global Drug Integrated Polymer Fibers Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drug Integrated Polymer Fibers Revenue in 2021
3.3 Global Drug Integrated Polymer Fibers Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drug Integrated Polymer Fibers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drug Integrated Polymer Fibers Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drug Integrated Polymer Fibers Sales by Type
4.1.1 Global Drug Integrated Polymer Fibers Historical Sales by Type (2017-2022)
4.1.2 Global Drug Integrated Polymer Fibers Forecasted Sales by Type (2023-2028)
4.1.3 Global Drug Integrated Polymer Fibers Sales Market Share by Type (2017-2028)
4.2 Global Drug Integrated Polymer Fibers Revenue by Type
4.2.1 Global Drug Integrated Polymer Fibers Historical Revenue by Type (2017-2022)
4.2.2 Global Drug Integrated Polymer Fibers Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drug Integrated Polymer Fibers Revenue Market Share by Type (2017-2028)
4.3 Global Drug Integrated Polymer Fibers Price by Type
4.3.1 Global Drug Integrated Polymer Fibers Price by Type (2017-2022)
4.3.2 Global Drug Integrated Polymer Fibers Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drug Integrated Polymer Fibers Sales by Application
5.1.1 Global Drug Integrated Polymer Fibers Historical Sales by Application (2017-2022)
5.1.2 Global Drug Integrated Polymer Fibers Forecasted Sales by Application (2023-2028)
5.1.3 Global Drug Integrated Polymer Fibers Sales Market Share by Application (2017-2028)
5.2 Global Drug Integrated Polymer Fibers Revenue by Application
5.2.1 Global Drug Integrated Polymer Fibers Historical Revenue by Application (2017-2022)
5.2.2 Global Drug Integrated Polymer Fibers Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drug Integrated Polymer Fibers Revenue Market Share by Application (2017-2028)
5.3 Global Drug Integrated Polymer Fibers Price by Application
5.3.1 Global Drug Integrated Polymer Fibers Price by Application (2017-2022)
5.3.2 Global Drug Integrated Polymer Fibers Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drug Integrated Polymer Fibers Market Size by Type
6.1.1 North America Drug Integrated Polymer Fibers Sales by Type (2017-2028)
6.1.2 North America Drug Integrated Polymer Fibers Revenue by Type (2017-2028)
6.2 North America Drug Integrated Polymer Fibers Market Size by Application
6.2.1 North America Drug Integrated Polymer Fibers Sales by Application (2017-2028)
6.2.2 North America Drug Integrated Polymer Fibers Revenue by Application (2017-2028)
6.3 North America Drug Integrated Polymer Fibers Market Size by Country
6.3.1 North America Drug Integrated Polymer Fibers Sales by Country (2017-2028)
6.3.2 North America Drug Integrated Polymer Fibers Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Drug Integrated Polymer Fibers Market Size by Type
7.1.1 Europe Drug Integrated Polymer Fibers Sales by Type (2017-2028)
7.1.2 Europe Drug Integrated Polymer Fibers Revenue by Type (2017-2028)
7.2 Europe Drug Integrated Polymer Fibers Market Size by Application
7.2.1 Europe Drug Integrated Polymer Fibers Sales by Application (2017-2028)
7.2.2 Europe Drug Integrated Polymer Fibers Revenue by Application (2017-2028)
7.3 Europe Drug Integrated Polymer Fibers Market Size by Country
7.3.1 Europe Drug Integrated Polymer Fibers Sales by Country (2017-2028)
7.3.2 Europe Drug Integrated Polymer Fibers Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drug Integrated Polymer Fibers Market Size by Type
8.1.1 Asia Pacific Drug Integrated Polymer Fibers Sales by Type (2017-2028)
8.1.2 Asia Pacific Drug Integrated Polymer Fibers Revenue by Type (2017-2028)
8.2 Asia Pacific Drug Integrated Polymer Fibers Market Size by Application
8.2.1 Asia Pacific Drug Integrated Polymer Fibers Sales by Application (2017-2028)
8.2.2 Asia Pacific Drug Integrated Polymer Fibers Revenue by Application (2017-2028)
8.3 Asia Pacific Drug Integrated Polymer Fibers Market Size by Region
8.3.1 Asia Pacific Drug Integrated Polymer Fibers Sales by Region (2017-2028)
8.3.2 Asia Pacific Drug Integrated Polymer Fibers Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Drug Integrated Polymer Fibers Market Size by Type
9.1.1 Latin America Drug Integrated Polymer Fibers Sales by Type (2017-2028)
9.1.2 Latin America Drug Integrated Polymer Fibers Revenue by Type (2017-2028)
9.2 Latin America Drug Integrated Polymer Fibers Market Size by Application
9.2.1 Latin America Drug Integrated Polymer Fibers Sales by Application (2017-2028)
9.2.2 Latin America Drug Integrated Polymer Fibers Revenue by Application (2017-2028)
9.3 Latin America Drug Integrated Polymer Fibers Market Size by Country
9.3.1 Latin America Drug Integrated Polymer Fibers Sales by Country (2017-2028)
9.3.2 Latin America Drug Integrated Polymer Fibers Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Drug Integrated Polymer Fibers Market Size by Type
10.1.1 Middle East and Africa Drug Integrated Polymer Fibers Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drug Integrated Polymer Fibers Revenue by Type (2017-2028)
10.2 Middle East and Africa Drug Integrated Polymer Fibers Market Size by Application
10.2.1 Middle East and Africa Drug Integrated Polymer Fibers Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drug Integrated Polymer Fibers Revenue by Application (2017-2028)
10.3 Middle East and Africa Drug Integrated Polymer Fibers Market Size by Country
10.3.1 Middle East and Africa Drug Integrated Polymer Fibers Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drug Integrated Polymer Fibers Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 TissueGen
11.1.1 TissueGen Corporation Information
11.1.2 TissueGen Overview
11.1.3 TissueGen Drug Integrated Polymer Fibers Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 TissueGen Drug Integrated Polymer Fibers Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 TissueGen Recent Developments
11.2 Micro Engineering Solutions
11.2.1 Micro Engineering Solutions Corporation Information
11.2.2 Micro Engineering Solutions Overview
11.2.3 Micro Engineering Solutions Drug Integrated Polymer Fibers Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Micro Engineering Solutions Drug Integrated Polymer Fibers Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Micro Engineering Solutions Recent Developments
11.3 Integrated Polymer Solutions
11.3.1 Integrated Polymer Solutions Corporation Information
11.3.2 Integrated Polymer Solutions Overview
11.3.3 Integrated Polymer Solutions Drug Integrated Polymer Fibers Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Integrated Polymer Solutions Drug Integrated Polymer Fibers Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Integrated Polymer Solutions Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drug Integrated Polymer Fibers Industry Chain Analysis
12.2 Drug Integrated Polymer Fibers Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug Integrated Polymer Fibers Production Mode & Process
12.4 Drug Integrated Polymer Fibers Sales and Marketing
12.4.1 Drug Integrated Polymer Fibers Sales Channels
12.4.2 Drug Integrated Polymer Fibers Distributors
12.5 Drug Integrated Polymer Fibers Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drug Integrated Polymer Fibers Industry Trends
13.2 Drug Integrated Polymer Fibers Market Drivers
13.3 Drug Integrated Polymer Fibers Market Challenges
13.4 Drug Integrated Polymer Fibers Market Restraints
14 Key Findings in The Global Drug Integrated Polymer Fibers Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Drug Integrated Polymer Fibers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Polylactic Acid
    Table 3. Major Manufacturers of Polydioxanone
    Table 4. Major Manufacturers of Polycaprolactone
    Table 5. Global Drug Integrated Polymer Fibers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Drug Integrated Polymer Fibers Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Drug Integrated Polymer Fibers Sales by Region (2017-2022) & (K MT)
    Table 8. Global Drug Integrated Polymer Fibers Sales Market Share by Region (2017-2022)
    Table 9. Global Drug Integrated Polymer Fibers Sales by Region (2023-2028) & (K MT)
    Table 10. Global Drug Integrated Polymer Fibers Sales Market Share by Region (2023-2028)
    Table 11. Global Drug Integrated Polymer Fibers Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Drug Integrated Polymer Fibers Revenue Market Share by Region (2017-2022)
    Table 13. Global Drug Integrated Polymer Fibers Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Drug Integrated Polymer Fibers Revenue Market Share by Region (2023-2028)
    Table 15. Global Drug Integrated Polymer Fibers Sales by Manufacturers (2017-2022) & (K MT)
    Table 16. Global Drug Integrated Polymer Fibers Sales Share by Manufacturers (2017-2022)
    Table 17. Global Drug Integrated Polymer Fibers Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Drug Integrated Polymer Fibers Revenue Share by Manufacturers (2017-2022)
    Table 19. Drug Integrated Polymer Fibers Price by Manufacturers (2017-2022) &(USD/MT)
    Table 20. Global Drug Integrated Polymer Fibers Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Drug Integrated Polymer Fibers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Integrated Polymer Fibers as of 2021)
    Table 22. Drug Integrated Polymer Fibers Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Drug Integrated Polymer Fibers Product Offered
    Table 24. Date of Manufacturers Enter into Drug Integrated Polymer Fibers Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Drug Integrated Polymer Fibers Sales by Type (2017-2022) & (K MT)
    Table 27. Global Drug Integrated Polymer Fibers Sales by Type (2023-2028) & (K MT)
    Table 28. Global Drug Integrated Polymer Fibers Sales Share by Type (2017-2022)
    Table 29. Global Drug Integrated Polymer Fibers Sales Share by Type (2023-2028)
    Table 30. Global Drug Integrated Polymer Fibers Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Drug Integrated Polymer Fibers Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Drug Integrated Polymer Fibers Revenue Share by Type (2017-2022)
    Table 33. Global Drug Integrated Polymer Fibers Revenue Share by Type (2023-2028)
    Table 34. Drug Integrated Polymer Fibers Price by Type (2017-2022) & (USD/MT)
    Table 35. Global Drug Integrated Polymer Fibers Price Forecast by Type (2023-2028) & (USD/MT)
    Table 36. Global Drug Integrated Polymer Fibers Sales by Application (2017-2022) & (K MT)
    Table 37. Global Drug Integrated Polymer Fibers Sales by Application (2023-2028) & (K MT)
    Table 38. Global Drug Integrated Polymer Fibers Sales Share by Application (2017-2022)
    Table 39. Global Drug Integrated Polymer Fibers Sales Share by Application (2023-2028)
    Table 40. Global Drug Integrated Polymer Fibers Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Drug Integrated Polymer Fibers Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Drug Integrated Polymer Fibers Revenue Share by Application (2017-2022)
    Table 43. Global Drug Integrated Polymer Fibers Revenue Share by Application (2023-2028)
    Table 44. Drug Integrated Polymer Fibers Price by Application (2017-2022) & (USD/MT)
    Table 45. Global Drug Integrated Polymer Fibers Price Forecast by Application (2023-2028) & (USD/MT)
    Table 46. North America Drug Integrated Polymer Fibers Sales by Type (2017-2022) & (K MT)
    Table 47. North America Drug Integrated Polymer Fibers Sales by Type (2023-2028) & (K MT)
    Table 48. North America Drug Integrated Polymer Fibers Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Drug Integrated Polymer Fibers Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Drug Integrated Polymer Fibers Sales by Application (2017-2022) & (K MT)
    Table 51. North America Drug Integrated Polymer Fibers Sales by Application (2023-2028) & (K MT)
    Table 52. North America Drug Integrated Polymer Fibers Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Drug Integrated Polymer Fibers Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Drug Integrated Polymer Fibers Sales by Country (2017-2022) & (K MT)
    Table 55. North America Drug Integrated Polymer Fibers Sales by Country (2023-2028) & (K MT)
    Table 56. North America Drug Integrated Polymer Fibers Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Drug Integrated Polymer Fibers Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Drug Integrated Polymer Fibers Sales by Type (2017-2022) & (K MT)
    Table 59. Europe Drug Integrated Polymer Fibers Sales by Type (2023-2028) & (K MT)
    Table 60. Europe Drug Integrated Polymer Fibers Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Drug Integrated Polymer Fibers Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Drug Integrated Polymer Fibers Sales by Application (2017-2022) & (K MT)
    Table 63. Europe Drug Integrated Polymer Fibers Sales by Application (2023-2028) & (K MT)
    Table 64. Europe Drug Integrated Polymer Fibers Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Drug Integrated Polymer Fibers Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Drug Integrated Polymer Fibers Sales by Country (2017-2022) & (K MT)
    Table 67. Europe Drug Integrated Polymer Fibers Sales by Country (2023-2028) & (K MT)
    Table 68. Europe Drug Integrated Polymer Fibers Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Drug Integrated Polymer Fibers Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Drug Integrated Polymer Fibers Sales by Type (2017-2022) & (K MT)
    Table 71. Asia Pacific Drug Integrated Polymer Fibers Sales by Type (2023-2028) & (K MT)
    Table 72. Asia Pacific Drug Integrated Polymer Fibers Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Drug Integrated Polymer Fibers Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Drug Integrated Polymer Fibers Sales by Application (2017-2022) & (K MT)
    Table 75. Asia Pacific Drug Integrated Polymer Fibers Sales by Application (2023-2028) & (K MT)
    Table 76. Asia Pacific Drug Integrated Polymer Fibers Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Drug Integrated Polymer Fibers Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Drug Integrated Polymer Fibers Sales by Region (2017-2022) & (K MT)
    Table 79. Asia Pacific Drug Integrated Polymer Fibers Sales by Region (2023-2028) & (K MT)
    Table 80. Asia Pacific Drug Integrated Polymer Fibers Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Drug Integrated Polymer Fibers Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Drug Integrated Polymer Fibers Sales by Type (2017-2022) & (K MT)
    Table 83. Latin America Drug Integrated Polymer Fibers Sales by Type (2023-2028) & (K MT)
    Table 84. Latin America Drug Integrated Polymer Fibers Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Drug Integrated Polymer Fibers Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Drug Integrated Polymer Fibers Sales by Application (2017-2022) & (K MT)
    Table 87. Latin America Drug Integrated Polymer Fibers Sales by Application (2023-2028) & (K MT)
    Table 88. Latin America Drug Integrated Polymer Fibers Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Drug Integrated Polymer Fibers Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Drug Integrated Polymer Fibers Sales by Country (2017-2022) & (K MT)
    Table 91. Latin America Drug Integrated Polymer Fibers Sales by Country (2023-2028) & (K MT)
    Table 92. Latin America Drug Integrated Polymer Fibers Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Drug Integrated Polymer Fibers Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Drug Integrated Polymer Fibers Sales by Type (2017-2022) & (K MT)
    Table 95. Middle East and Africa Drug Integrated Polymer Fibers Sales by Type (2023-2028) & (K MT)
    Table 96. Middle East and Africa Drug Integrated Polymer Fibers Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Drug Integrated Polymer Fibers Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Drug Integrated Polymer Fibers Sales by Application (2017-2022) & (K MT)
    Table 99. Middle East and Africa Drug Integrated Polymer Fibers Sales by Application (2023-2028) & (K MT)
    Table 100. Middle East and Africa Drug Integrated Polymer Fibers Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Drug Integrated Polymer Fibers Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Drug Integrated Polymer Fibers Sales by Country (2017-2022) & (K MT)
    Table 103. Middle East and Africa Drug Integrated Polymer Fibers Sales by Country (2023-2028) & (K MT)
    Table 104. Middle East and Africa Drug Integrated Polymer Fibers Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Drug Integrated Polymer Fibers Revenue by Country (2023-2028) & (US$ Million)
    Table 106. TissueGen Corporation Information
    Table 107. TissueGen Description and Major Businesses
    Table 108. TissueGen Drug Integrated Polymer Fibers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 109. TissueGen Drug Integrated Polymer Fibers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. TissueGen Recent Developments
    Table 111. Micro Engineering Solutions Corporation Information
    Table 112. Micro Engineering Solutions Description and Major Businesses
    Table 113. Micro Engineering Solutions Drug Integrated Polymer Fibers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 114. Micro Engineering Solutions Drug Integrated Polymer Fibers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Micro Engineering Solutions Recent Developments
    Table 116. Integrated Polymer Solutions Corporation Information
    Table 117. Integrated Polymer Solutions Description and Major Businesses
    Table 118. Integrated Polymer Solutions Drug Integrated Polymer Fibers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 119. Integrated Polymer Solutions Drug Integrated Polymer Fibers Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Integrated Polymer Solutions Recent Developments
    Table 121. Key Raw Materials Lists
    Table 122. Raw Materials Key Suppliers Lists
    Table 123. Drug Integrated Polymer Fibers Distributors List
    Table 124. Drug Integrated Polymer Fibers Customers List
    Table 125. Drug Integrated Polymer Fibers Market Trends
    Table 126. Drug Integrated Polymer Fibers Market Drivers
    Table 127. Drug Integrated Polymer Fibers Market Challenges
    Table 128. Drug Integrated Polymer Fibers Market Restraints
    Table 129. Research Programs/Design for This Report
    Table 130. Key Data Information from Secondary Sources
    Table 131. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drug Integrated Polymer Fibers Product Picture
    Figure 3. Global Drug Integrated Polymer Fibers Market Share by Type in 2021 & 2028
    Figure 3. Polylactic Acid Product Picture
    Figure 4. Polydioxanone Product Picture
    Figure 5. Polycaprolactone Product Picture
    Figure 6. Global Drug Integrated Polymer Fibers Market Share by Application in 2021 & 2028
    Figure 7. Drug Delivery
    Figure 8. Orthopaedic Sutures
    Figure 9. Vascular Stents
    Figure 10. Vascular Grafts
    Figure 11. Dermal Wound Healing
    Figure 12. Drug Integrated Polymer Fibers Report Years Considered
    Figure 13. Global Drug Integrated Polymer Fibers Sales 2017-2028 (K MT)
    Figure 14. Global Drug Integrated Polymer Fibers Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Drug Integrated Polymer Fibers Revenue 2017-2028 (US$ Million)
    Figure 16. Global Drug Integrated Polymer Fibers Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 17. Global Drug Integrated Polymer Fibers Sales Market Share by Region (2017-2022)
    Figure 18. Global Drug Integrated Polymer Fibers Sales Market Share by Region (2023-2028)
    Figure 19. North America Drug Integrated Polymer Fibers Sales YoY (2017-2028) & (K MT)
    Figure 20. North America Drug Integrated Polymer Fibers Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Europe Drug Integrated Polymer Fibers Sales YoY (2017-2028) & (K MT)
    Figure 22. Europe Drug Integrated Polymer Fibers Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Asia-Pacific Drug Integrated Polymer Fibers Sales YoY (2017-2028) & (K MT)
    Figure 24. Asia-Pacific Drug Integrated Polymer Fibers Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Latin America Drug Integrated Polymer Fibers Sales YoY (2017-2028) & (K MT)
    Figure 26. Latin America Drug Integrated Polymer Fibers Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Middle East & Africa Drug Integrated Polymer Fibers Sales YoY (2017-2028) & (K MT)
    Figure 28. Middle East & Africa Drug Integrated Polymer Fibers Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. The Drug Integrated Polymer Fibers Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 30. The Top 5 and 10 Largest Manufacturers of Drug Integrated Polymer Fibers in the World: Market Share by Drug Integrated Polymer Fibers Revenue in 2021
    Figure 31. Global Drug Integrated Polymer Fibers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 32. Global Drug Integrated Polymer Fibers Sales Market Share by Type (2017-2028)
    Figure 33. Global Drug Integrated Polymer Fibers Revenue Market Share by Type (2017-2028)
    Figure 34. Global Drug Integrated Polymer Fibers Sales Market Share by Application (2017-2028)
    Figure 35. Global Drug Integrated Polymer Fibers Revenue Market Share by Application (2017-2028)
    Figure 36. North America Drug Integrated Polymer Fibers Sales Market Share by Type (2017-2028)
    Figure 37. North America Drug Integrated Polymer Fibers Revenue Market Share by Type (2017-2028)
    Figure 38. North America Drug Integrated Polymer Fibers Sales Market Share by Application (2017-2028)
    Figure 39. North America Drug Integrated Polymer Fibers Revenue Market Share by Application (2017-2028)
    Figure 40. North America Drug Integrated Polymer Fibers Sales Share by Country (2017-2028)
    Figure 41. North America Drug Integrated Polymer Fibers Revenue Share by Country (2017-2028)
    Figure 42. U.S. Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 43. Canada Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 44. Europe Drug Integrated Polymer Fibers Sales Market Share by Type (2017-2028)
    Figure 45. Europe Drug Integrated Polymer Fibers Revenue Market Share by Type (2017-2028)
    Figure 46. Europe Drug Integrated Polymer Fibers Sales Market Share by Application (2017-2028)
    Figure 47. Europe Drug Integrated Polymer Fibers Revenue Market Share by Application (2017-2028)
    Figure 48. Europe Drug Integrated Polymer Fibers Sales Share by Country (2017-2028)
    Figure 49. Europe Drug Integrated Polymer Fibers Revenue Share by Country (2017-2028)
    Figure 50. Germany Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 51. France Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 52. U.K. Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 53. Italy Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 54. Russia Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 55. Asia Pacific Drug Integrated Polymer Fibers Sales Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Drug Integrated Polymer Fibers Revenue Market Share by Type (2017-2028)
    Figure 57. Asia Pacific Drug Integrated Polymer Fibers Sales Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Drug Integrated Polymer Fibers Revenue Market Share by Application (2017-2028)
    Figure 59. Asia Pacific Drug Integrated Polymer Fibers Sales Share by Region (2017-2028)
    Figure 60. Asia Pacific Drug Integrated Polymer Fibers Revenue Share by Region (2017-2028)
    Figure 61. China Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 62. Japan Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 63. South Korea Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 64. India Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 65. Australia Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 66. Taiwan Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 67. Indonesia Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 68. Thailand Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 69. Malaysia Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 70. Philippines Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 71. Latin America Drug Integrated Polymer Fibers Sales Market Share by Type (2017-2028)
    Figure 72. Latin America Drug Integrated Polymer Fibers Revenue Market Share by Type (2017-2028)
    Figure 73. Latin America Drug Integrated Polymer Fibers Sales Market Share by Application (2017-2028)
    Figure 74. Latin America Drug Integrated Polymer Fibers Revenue Market Share by Application (2017-2028)
    Figure 75. Latin America Drug Integrated Polymer Fibers Sales Share by Country (2017-2028)
    Figure 76. Latin America Drug Integrated Polymer Fibers Revenue Share by Country (2017-2028)
    Figure 77. Mexico Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 78. Brazil Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 79. Argentina Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 80. Middle East and Africa Drug Integrated Polymer Fibers Sales Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Drug Integrated Polymer Fibers Revenue Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa Drug Integrated Polymer Fibers Sales Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Drug Integrated Polymer Fibers Revenue Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa Drug Integrated Polymer Fibers Sales Share by Country (2017-2028)
    Figure 85. Middle East and Africa Drug Integrated Polymer Fibers Revenue Share by Country (2017-2028)
    Figure 86. Turkey Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 87. Saudi Arabia Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 88. U.A.E Drug Integrated Polymer Fibers Revenue (2017-2028) & (US$ Million)
    Figure 89. Drug Integrated Polymer Fibers Value Chain
    Figure 90. Drug Integrated Polymer Fibers Production Process
    Figure 91. Channels of Distribution
    Figure 92. Distributors Profiles
    Figure 93. Bottom-up and Top-down Approaches for This Report
    Figure 94. Data Triangulation
    Figure 95. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona

RELATED REPORTS

Global ABS Composite Resin Market Insights Forecast to 2028
Global ABS Composite Resin Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-38F7474
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Motor Vehicle Thermoplastic Elastomer Market Insights Forecast to 2028
Global Motor Vehicle Thermoplastic Elastomer Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-3E8262
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global Clear Acrylic Sheets Market Insights Forecast to 2028
Global Clear Acrylic Sheets Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-0A7902
Tue May 03 00:00:00 UTC 2022

Add to Cart

Global High Density Polyethylene Impermeable Membrane Market Insights and Forecast to 2028
Global High Density Polyethylene Impermeable Membrane Market Insights and Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-28I7692
Tue May 03 00:00:00 UTC 2022

Add to Cart